News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,061 Results
Type
Article (39545)
Company Profile (247)
Press Release (656269)
Section
Business (204099)
Career Advice (2007)
Deals (35413)
Drug Delivery (94)
Drug Development (81008)
Employer Resources (172)
FDA (16153)
Job Trends (14843)
News (345039)
Policy (32496)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49364)
ALS (83)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (108)
Approvals (16155)
Artificial intelligence (228)
Autoimmune disease (14)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (24)
Breast cancer (246)
Cancer (1989)
Cardiovascular disease (160)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (395)
Cervical cancer (18)
Clinical research (65697)
Collaboration (763)
Compensation (449)
Complete response letters (19)
COVID-19 (2580)
CRISPR (35)
C-suite (210)
Cystic fibrosis (98)
Data (1951)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (248)
Diagnostics (6329)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86199)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111634)
Executive appointments (638)
FDA (17254)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (96)
Generative AI (18)
Gene therapy (276)
GLP-1 (684)
Government (4377)
Grass and pollen (4)
Guidances (48)
Healthcare (18805)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2710)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (86)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (452)
Leadership (15)
Legal (7899)
Liver cancer (70)
Lung cancer (291)
Lymphoma (133)
Machine learning (4)
Management (58)
Manufacturing (265)
MASH (60)
Medical device (13319)
Medtech (13324)
Mergers & acquisitions (19397)
Metabolic disorders (629)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1821)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2417)
Now hiring (37)
Obesity (339)
Opinion (201)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (132)
Partnered (20)
Patents (203)
Patient recruitment (93)
Peanut (46)
People (57075)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20461)
Phase II (28931)
Phase III (21563)
Pipeline (1024)
Podcasts (44)
Policy (110)
Postmarket research (2563)
Preclinical (8653)
Press Release (64)
Prostate cancer (93)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (355)
Real estate (5900)
Recruiting (65)
Regulatory (22132)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (50)
Southern California (2094)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (25)
United States (21084)
Vaccines (656)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (243)
Last 7 days (739)
Last 30 days (2735)
Last 365 days (33670)
2025 (7958)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46539)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37705)
Australia (6162)
California (5511)
Canada (1863)
China (474)
Colorado (245)
Connecticut (256)
Delaware (125)
Europe (80831)
Florida (818)
Georgia (192)
Idaho (57)
Illinois (494)
India (23)
Indiana (290)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (826)
Massachusetts (4144)
Michigan (209)
Minnesota (369)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1571)
New Mexico (28)
New York (1582)
North Carolina (916)
North Dakota (7)
Northern California (2417)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1253)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2094)
Tennessee (92)
Texas (821)
Utah (164)
Virginia (128)
Washington D.C. (57)
Washington State (512)
West Virginia (3)
Wisconsin (49)
696,061 Results for "opgen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OpGen Provides Update on Business Operations and Strategic Opportunities
OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it entered into an agreement to sell its commercial customer contracts and installed base of Unyvero systems to Camtech Pte Ltd (“Camtech”), a Singaporean family office for $218,000.
April 29, 2024
·
3 min read
BioCapital
OpGen Announced 1-for-10 Reverse Stock Split - May 16, 2024
OpGen, Inc. announced that the Company’s board of directors has approved a 1-for-10 reverse stock split of its shares of common stock.
May 16, 2024
·
4 min read
BioCapital
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
OpGen, Inc. announced that it received a notice from The Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5250 due to the Company not filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
April 23, 2024
·
3 min read
Deals
OpGen Announces Acquisition of Preferred Stock by David Lazar
OpGen, Inc., announced that the Company entered into a securities purchase agreement with David E. Lazar, an experienced private investor, pursuant to which he will acquire 3,000,000 shares of Series E Convertible Preferred Stock of the Company at a price of $1.00 per share for aggregate gross proceeds of $3.0 million.
March 25, 2024
·
6 min read
BioCapital
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - May 24, 2024
OpGen, Inc. announced that it received a notice from The Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5250 due to the Company not filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024, which serves as an additional basis for delisting the Company’s securities from Nasdaq, and that the Nasdaq Hearings Panel will consider this matter in connection with the continued listing of the Company’s securities on Nasdaq.
May 24, 2024
·
3 min read
Business
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported its third quarter 2023 financial and operating results.
November 14, 2023
·
10 min read
BioCapital
OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
OpGen, Inc. announced today a major feature upgrade for the AREScloud platform that has been implemented with our healthcare clients to enhance genomic surveillance.
August 7, 2023
·
4 min read
Business
OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported that its German subsidiary Curetis GmbH has signed an extended and continued research and development collaboration agreement with FIND.
August 3, 2023
·
6 min read
Business
OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
OpGen, Inc. reported today that its German subsidiary Curetis GmbH has met all milestones under its extended and expanded research and development (“R&D”) collaboration agreement with FIND.
July 19, 2023
·
5 min read
Business
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported its second quarter and first half of 2023 financial and operating results.
August 10, 2023
·
11 min read
1 of 69,607
Next